Basic Study
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer

World J Clin Oncol
7(6):425-432.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.425
Abstract (1366)
|
Core Tip (1169)
|
Full Article (HTML) (3829)
|
Figures (1-2) (452)
|
Tables (1-2) (409)
|
Full Article (PDF)-2061K (471)
|
Audio-594K (61)
|
Peer-Review Report-120K (258)
|
Answering Reviewers-141K (303)
|
Received: 06/20/2016
|
Revised: 08/12/2016
|
Accepted: 10/27/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (14052)
|
Similar Articles (99)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Clin Oncol
7(6):433-440.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.433
Abstract (1357)
|
Core Tip (1297)
|
Full Article (HTML) (4167)
|
Figures (1-3) (848)
|
Tables (1-2) (473)
|
Full Article (PDF)-1143K (516)
|
Audio-1781K (23)
|
Peer-Review Report-120K (271)
|
Answering Reviewers-566K (353)
|
Received: 08/03/2016
|
Revised: 09/10/2016
|
Accepted: 10/18/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (16980)
|
Similar Articles (1021)
|
Timeline of Article Publication (0)
|
Authors Evaluation (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open